Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaerim Kim

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
Journal of Critical Care|December 25, 2025
Machine learning survival analysis for predicting kidney disease progression in patients with acute kidney injury undergoing continuous kidney replacement therapy: An analysis of the LINKA databaseDonghwan Yun, Ari Hong, Kwangsoo Kim, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 16, 2025
Associations of Skeletal Muscle Mass and Body Mass Index With Clinical Outcomes in Autosomal-Dominant Polycystic Kidney Disease: An Observational StudyDha Woon Im, Jiyun Jung, Miso Ha, et al.
BMJ Open|October 11, 2020
'A sword of Damocles': patient and caregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominant polycystic kidney disease: a focus group studyCharlotte Logeman, Yeoungjee Cho, Benedicte Sautenet, et al.
Kidney Research and Clinical Practice|January 12, 2023
Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration periodHyuk Huh, Yong Soo Kim, Wookyung Chung, et al.
Kidney Research and Clinical Practice|October 9, 2024
Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): final reportHayne Cho Park, Yong Chul Kim, Hyunsuk Kim, et al.
Nephrology (Carlton, Vic.)|January 22, 2019
Identifying patient-important outcomes in polycystic kidney disease: An international nominal group technique studyYeoungjee Cho, Benedicte Sautenet, Talia Gutman, et al.
BMC Nephrology|August 27, 2020
Biobanking for glomerular diseases: a study design and protocol for KOrea Renal biobank NEtwoRk System TOward NExt-generation analysis (KORNERSTONE)Eunjeong Kang, Yaerim Kim, Yong Chul Kim, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 22, 2019
Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III StudyYaerim Kim, Su-Kil Park, Won Yong Cho, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Journal of Critical Care|December 25, 2025
Machine learning survival analysis for predicting kidney disease progression in patients with acute kidney injury undergoing continuous kidney replacement therapy: An analysis of the LINKA databaseDonghwan Yun, Ari Hong, Kwangsoo Kim, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 16, 2025
Associations of Skeletal Muscle Mass and Body Mass Index With Clinical Outcomes in Autosomal-Dominant Polycystic Kidney Disease: An Observational StudyDha Woon Im, Jiyun Jung, Miso Ha, et al.
BMJ Open|October 11, 2020
'A sword of Damocles': patient and caregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominant polycystic kidney disease: a focus group studyCharlotte Logeman, Yeoungjee Cho, Benedicte Sautenet, et al.
Kidney Research and Clinical Practice|January 12, 2023
Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration periodHyuk Huh, Yong Soo Kim, Wookyung Chung, et al.
Kidney Research and Clinical Practice|October 9, 2024
Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): final reportHayne Cho Park, Yong Chul Kim, Hyunsuk Kim, et al.
Nephrology (Carlton, Vic.)|January 22, 2019
Identifying patient-important outcomes in polycystic kidney disease: An international nominal group technique studyYeoungjee Cho, Benedicte Sautenet, Talia Gutman, et al.
BMC Nephrology|August 27, 2020
Biobanking for glomerular diseases: a study design and protocol for KOrea Renal biobank NEtwoRk System TOward NExt-generation analysis (KORNERSTONE)Eunjeong Kang, Yaerim Kim, Yong Chul Kim, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 22, 2019
Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III StudyYaerim Kim, Su-Kil Park, Won Yong Cho, et al.
Pageof 15